Claros Diagnostics Inc.

Claros Diagnostics Inc. specializes in advanced medical diagnostic technologies, focusing on innovative solutions for healthcare challenges through cutting-edge research and development. Founded in 2004 in Woburn, US, Claros Diagnostics Inc. focuses on developing and commercializing point-of-care diagnostics.

In October 2011, it was acquired by OPKO Health, Inc. for USD 49 mn, allowing OPKO to enhance its diagnostic technology portfolio. The firm has successfully completed three deals. Claros Diagnostics Inc.

is known for its innovative diagnostic solutions designed to facilitate healthcare delivery. The company specializes in point-of-care testing, enabling quick and accurate diagnostics to aid in clinical decision-making. Its technology aims to improve patient outcomes through timely diagnostics, making healthcare more accessible and efficient. Claros Diagnostics Inc.

generates revenue through the sale of its diagnostic products, which are marketed to healthcare providers and institutions. The company leverages strategic partnerships to enhance its market presence and drive sales growth. Revenue streams are primarily derived from product sales and collaborations within the healthcare sector. Following its acquisition by OPKO Health, Inc.

, Claros Diagnostics Inc. will contribute to developing next-generation diagnostic technologies. The company aims to expand its product offerings and market reach with support from the USD 49 mn acquisition funding. This initiative includes exploring new markets and regions, particularly in North America and Europe, as well as focusing on the launch of innovative diagnostic solutions designed to address unmet needs in healthcare.